.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent advancements in nanomedicine have introduced NIR-II photothermal ablation as a promising frontier for targeted breast cancer therapy. A groundbreaking study reveals a microfluidic assembly strategy for creating highly uniform nanoparticles that improve both imaging and treatment outcomes. Furthermore, these nanoparticles exhibit exceptional photostability. Consequently, they remain effective throughout the procedure.
The near-infrared-II (NIR-II) window allows for deeper tissue penetration and higher contrast imaging compared to traditional methods. Specifically, the scattering and absorption of photons by biological tissues are significantly reduced in this range. Additionally, this allows for precise tumor localization and effective photothermal conversion. Consequently, clinicians can achieve complete tumor ablation with minimal damage to healthy surrounding tissues.
Achieving consistent nanoparticle size is often challenging with conventional batch methods. However, researchers successfully utilized a microfluidic strategy to assemble NDA-MEPA nanoparticles. This technique ensures reproducible control over the 40 nm particle size. Importantly, surface encapsulation with DSPE-PEG2K confers excellent colloidal stability and biocompatibility. As a result, the particles show enhanced tumor accumulation and efficient cellular uptake.
In vivo studies demonstrate that these nanoparticles enable high-contrast fluorescence imaging. This dual-purpose platform allows clinicians to visualize the tumor while performing thermal ablation simultaneously. Furthermore, the study reported minimal systemic toxicity. These findings highlight a biocompatible platform with strong potential for translational cancer therapy in India and globally.
NIR-II photothermal ablation offers deeper tissue penetration and higher image resolution than the NIR-I window. This allows for safer and more effective treatment of deep-seated breast tumors while sparing normal tissue.
Microfluidic assembly provides precise control over particle size and uniformity. This consistency is crucial for predictable biodistribution, enhanced tumor targeting, and successful clinical translation in the field of oncology.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ji X et al. Microfluidic Assembly of NIR-II AIE Nanoparticles for Enhanced Photothermal Ablation of Breast Tumors. Adv Healthc Mater. 2026 May 02. doi: 10.1002/adhm.71201. PMID: 42068191.
Li J, et al. AIEgens for Biological Imaging and Therapy. Chemical Reviews. 2024.
Wang S, et al. Advances in Microfluidic Synthesis of Nanomedicines. Nanoscale Horizons. 2025.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers have developed a microfluidic approach to assemble NIR-II AIE nanoparticles for precise photothermal ablation and imaging of breast tumors....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
